HealthcareServices

Patient Risk Stratification Market to Grow at a CAGR of 30.7% from 2025 to 2029

November 26, 2025 by Marketing Posting

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Are The Growth Projections For The Patient Risk Stratification Market Size During 2025–2029?

The patient risk stratification market has experienced significant expansion in recent years. It is forecast to grow from $2.15 billion in 2024 to $2.81 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 30.9%. The market’s historical development can be ascribed to a range of factors, including the increased embrace of digitization, elevated risk, an expanding geriatric population, a rising occurrence of medical errors, and the broader implementation of electronic health records (EHR).

The patient risk stratification market is projected to experience substantial expansion in the coming years. Its valuation is anticipated to reach $8.2 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 30.7%. Factors contributing to this growth over the projected period include an expanding middle class and increased health insurance coverage, a rise in chronic disease prevalence, the increasing uptake of predictive analytics, greater focus on social determinants of health (SDOH), and the broader implementation of technology. Key trends expected during the forecast timeframe encompass progress in analytics, artificial intelligence (AI), machine learning, general technological progress, novel tools, specific technological improvements within healthcare, wearable devices, and remote patient surveillance.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20917&type=smp

What Are The Emerging Market Drivers Creating New Opportunities In The Patient Risk Stratification Industry?

The increasing prevalence of chronic illnesses is anticipated to drive the expansion of the patient risk stratification market in the future. Chronic diseases are defined as persistent health conditions enduring for prolonged durations, generally three months or more. This rising burden of chronic diseases stems from factors such as an aging demographic, unhealthy habits, increasing urbanization, environmental influences, restricted access to healthcare, economic inequalities, and elevated stress. Patient risk stratification facilitates the identification of individuals at varying risk levels for chronic conditions, thereby enabling tailored care, prompt intervention, optimized resource distribution, and enhanced health results. For example, data from January 2023 by the National Center for Biotechnology Information (NCBI), a US-based National Library of Medicine, indicates that the population aged 50 and above suffering from at least one chronic illness is predicted to grow by 99.5%, rising from 71.522 million in 2020 to 142.66 million by 2050. Additionally, the World Health Organization (WHO) 2022 Highlights, published in September 2022 by the Switzerland-based intergovernmental health organization, reported that chronic diseases were responsible for 74% of all worldwide fatalities, totaling 41 million deaths each year. Among these, cardiovascular diseases led to 17.9 million deaths, cancer to 9.3 million, chronic respiratory diseases to 4.1 million, and diabetes to 2.0 million deaths. Consequently, the escalating burden posed by chronic diseases is a key factor propelling the patient risk stratification market.

What Are The Segment Types Shaping The Patient Risk Stratification Market?

The patient risk stratificationmarket covered in this report is segmented –

1) By Type: Predictive Risk Stratification Model; Retrospective Risk Stratification Model; Prospective Risk Stratification Model; Concurrent Risk Stratification Model

2) By Component: Software; Services

3) By Delivery Model: On-Premise; Cloud-Based

4) By Application: Risk Adjustment; Clinical Workflow; Revenue Cycle Management; Other Applications

5) By End User: Healthcare Providers; Healthcare Payers; Other End Users

Subsegments:

1) By Predictive Risk Stratification Model: Machine Learning-Based Predictive Models; Statistical Predictive Models; AI-Powered Predictive Models

2) By Retrospective Risk Stratification Model: Historical Data-Based Risk Models; Data Mining Retrospective Models

3) By Prospective Risk Stratification Model: Longitudinal Cohort-Based Models; Real-Time Risk Assessment Models

4) By Concurrent Risk Stratification Model: In-Hospital Risk Assessment Models; Real-Time Clinical Decision Support Models

What Key Innovation Trends Are Fueling Advancements In The Patient Risk Stratification Market?

Leading firms in the patient risk stratification market are prioritizing technological innovations in healthcare, notably artificial intelligence (AI) for disease screening. This strategic emphasis aims to bolster early detection, elevate patient well-being, and decrease healthcare expenditures through more precise risk evaluations and individualized treatment strategies. AI-driven disease screening employs advanced algorithms and machine learning techniques to analyze medical information, facilitating prompt disease identification and enhancing diagnostic precision by rapidly processing extensive datasets. A pertinent example occurred in May 2024, when WELL Health Technologies Corporation, a Canadian healthcare entity, and its associated company HEALWELL AI, also a Canadian healthcare firm specializing in AI and data science for preventive care, introduced WELL AI Decision Support (WAIDS). Initially designed for rare diseases, this system has expanded to include screening for prevalent chronic conditions like kidney disease, hypertension, and diabetes. WAIDS possesses the capability to identify more than 100 diseases and offer risk stratification, thereby assisting clinicians in pinpointing care deficiencies and accessing relevant data directly at the point of care.

Who Are The Core Companies Influencing The Patient Risk Stratification Market Landscape?

Major companies operating in the patient risk stratification market are Bristol-Myers Squibb, Thermo Fisher Scientific Inc., Abbott Laboratories, Sales Force Inc., Medtronic plc, Siemens Healthineers AG, Koninklijke Philips N.V., GE HealthCare Technologies Inc., Adobe Inc., Persistent Systems, NextGen Healthcare Inc., Health Catalyst, Freenome, Strive Health, Medeanalytics Inc., American Academy of Family Physicians, Lightbeam Health Solutions, Graphnet Health Ltd., Innova Medical Group Inc., Equipo Health Inc., Epic Systems Corporation

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/patient-risk-stratification-global-market-report

Which Region Is Projected To Lead The Patient Risk Stratification Market During The Forecast Period?

North America was the largest region in the patient risk stratification market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the patient risk stratification market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Patient Risk Stratification Market Report:

https://www.thebusinessresearchcompany.com/customise?id=20917&type=smp

Browse Through More Reports Similar to the Global Patient Risk Stratification Market 2025, By The Business Research Company

Patient Portal Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/patient-portal-global-market-report

Patient Safety And Risk Management Software Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/patient-safety-and-risk-management-software-global-market-report

Patient Registry Software Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/patient-registry-software-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795